PRESS RELEASE published on 02/07/2024 at 15:00, 9 months 13 days ago Protenus is Awarded Top-Performing Solutions Vendor in Two Segments for Second Consecutive Year Based on 2024 Best in KLAS Report Protenus, a healthcare compliance analytics platform, achieves highest score for patient privacy monitoring and drug diversion surveillance solutions for the second year in a row, as reported by 2024 Best in KLAS: Software & Services. Protenus' AI-driven solutions help healthcare organizations nationwide to proactively identify and prevent privacy data breaches and drug diversion, reducing manual tasks and focusing on better risk-reduction outcomes Protenus Healthcare Compliance Analytics Patient Privacy Monitoring Drug Diversion Surveillance Best In KLAS
PRESS RELEASE published on 10/26/2023 at 14:00, 1 year ago Protenus Granted Fifth New Patent for Drug Diversion Surveillance Technology
PRESS RELEASE published on 06/22/2023 at 18:00, 1 year 4 months ago New 2023 Diversion Digest From Protenus Spotlights the Prevalence of Drug Diversion in Healthcare
PRESS RELEASE published on 03/08/2023 at 18:00, 1 year 8 months ago Protenus Earns Fourth Great Place to Work Certification
Published on 11/21/2024 at 14:15, 7 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 22 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 22 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 22 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 6 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 7 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 47 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 24 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 2 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 37 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 37 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
